Skip to main content

Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction?

Publication ,  Journal Article
Michalak, M; Armstrong, PW
Published in: Circ Heart Fail
March 2018

Duke Scholars

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

March 2018

Volume

11

Issue

3

Start / End Page

e004813

Location

United States

Related Subject Headings

  • Soluble Guanylyl Cyclase
  • Humans
  • Heart Failure
  • Enzyme Activators
  • Cyclic GMP
  • Cardiovascular System & Hematology
  • Cardiovascular System
  • 3208 Medical physiology
  • 3201 Cardiovascular medicine and haematology
  • 1116 Medical Physiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Michalak, M., & Armstrong, P. W. (2018). Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction? Circ Heart Fail, 11(3), e004813. https://doi.org/10.1161/CIRCHEARTFAILURE.118.004813
Michalak, Marek, and Paul W. Armstrong. “Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction?Circ Heart Fail 11, no. 3 (March 2018): e004813. https://doi.org/10.1161/CIRCHEARTFAILURE.118.004813.
Michalak, Marek, and Paul W. Armstrong. “Exploring New Cardiovascular Pathways: Are Soluble Guanylate Cyclase Stimulators the Right Direction?Circ Heart Fail, vol. 11, no. 3, Mar. 2018, p. e004813. Pubmed, doi:10.1161/CIRCHEARTFAILURE.118.004813.

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

March 2018

Volume

11

Issue

3

Start / End Page

e004813

Location

United States

Related Subject Headings

  • Soluble Guanylyl Cyclase
  • Humans
  • Heart Failure
  • Enzyme Activators
  • Cyclic GMP
  • Cardiovascular System & Hematology
  • Cardiovascular System
  • 3208 Medical physiology
  • 3201 Cardiovascular medicine and haematology
  • 1116 Medical Physiology